188 related articles for article (PubMed ID: 15504816)
21. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
[TBL] [Abstract][Full Text] [Related]
22. Broncho-bronchiolitis obliterans after living-donor lung transplantation: a unique manifestation of chronic allograft rejection.
Sakurai H; Morishima Y; Itoguchi N; Ohtsuka S; Yamadori I; Oto T; Ishii Y; Sakamoto T; Noguchi M; Hizawa N
Transplantation; 2013 Aug; 96(4):e29-30. PubMed ID: 23958888
[No Abstract] [Full Text] [Related]
23. Innate immunity influences long-term outcomes after human lung transplant.
Palmer SM; Burch LH; Trindade AJ; Davis RD; Herczyk WF; Reinsmoen NL; Schwartz DA
Am J Respir Crit Care Med; 2005 Apr; 171(7):780-5. PubMed ID: 15640363
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
[TBL] [Abstract][Full Text] [Related]
25. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
[TBL] [Abstract][Full Text] [Related]
26. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy.
Kramer MR; Stoehr C; Whang JL; Berry GJ; Sibley R; Marshall SE; Patterson GM; Starnes VA; Theodore J
J Heart Lung Transplant; 1993; 12(4):675-81. PubMed ID: 8369329
[TBL] [Abstract][Full Text] [Related]
27. Bronchiolitis obliterans: an update.
Chan A; Allen R
Curr Opin Pulm Med; 2004 Mar; 10(2):133-41. PubMed ID: 15021183
[TBL] [Abstract][Full Text] [Related]
28. Obliterative bronchiolitis.
Kelly K; Hertz MI
Clin Chest Med; 1997 Jun; 18(2):319-38. PubMed ID: 9187825
[TBL] [Abstract][Full Text] [Related]
29. [Directing patients after lung transplantation with regard to complications].
Wojarski J; Zembala M; Religa Z; Nozyński J
Pneumonol Alergol Pol; 1995; 63(1-2):93-8. PubMed ID: 7633378
[No Abstract] [Full Text] [Related]
30. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
31. The immunohistopathology of obliterative bronchiolitis following lung transplantation.
Milne DS; Gascoigne A; Wilkes J; Sviland L; Ashcroft T; Pearson AD; Malcolm AJ; Corris P
Transplantation; 1992 Oct; 54(4):748-50. PubMed ID: 1412772
[No Abstract] [Full Text] [Related]
32. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans?
Yousem SA; Dauber JA; Keenan R; Paradis IL; Zeevi A; Griffith BP
Transplantation; 1991 Aug; 52(2):306-9. PubMed ID: 1871804
[TBL] [Abstract][Full Text] [Related]
33. Bronchiolitis obliterans: the Achilles heel of lung transplantation.
Frost AE
Verh K Acad Geneeskd Belg; 2002; 64(5):303-19; discussion 319-22. PubMed ID: 12647579
[TBL] [Abstract][Full Text] [Related]
34. Lung transplantation in the fischer 344-wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the rat.
von Süßkind-Schwendi M; Ruemmele P; Schmid C; Hirt SW; Lehle K
Exp Lung Res; 2012 Apr; 38(3):111-23. PubMed ID: 22394285
[TBL] [Abstract][Full Text] [Related]
35. Statin use is associated with improved function and survival of lung allografts.
Johnson BA; Iacono AT; Zeevi A; McCurry KR; Duncan SR
Am J Respir Crit Care Med; 2003 May; 167(9):1271-8. PubMed ID: 12615629
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
[TBL] [Abstract][Full Text] [Related]
37. Obliterative bronchiolitis in the lung transplant recipient. A powerful foe.
Smith-Seiler DA; Iacono AT
Adv Nurse Pract; 2004 Apr; 12(4):69-74. PubMed ID: 15101139
[No Abstract] [Full Text] [Related]
38. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
39. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
[TBL] [Abstract][Full Text] [Related]
40. Posttransplantation physiologic features of the lung and obliterative bronchiolitis.
Scott JP; Peters SG; McDougall JC; Beck KC; Midthun DE
Mayo Clin Proc; 1997 Feb; 72(2):170-4. PubMed ID: 9033552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
